Debt AdvisoryHealthcarePUBLISHED
Kasvu Therapeutics Raises €30 Million Series A Financing Round
Value
€30M
Target
Kasvu Therapeutics
Kasvu Therapeutics has announced a €30 million Series A financing round led by Hadean Ventures. The funds will be used to advance its novel TrkB potentiator into clinical development for neuropsychiatric disorders.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.